| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 40.04B | 40.59B | 39.97B | 39.73B | 39.57B | 36.74B |
| Gross Profit | 12.08B | 12.37B | 11.99B | 12.07B | 11.61B | 10.73B |
| EBITDA | 3.19B | 3.14B | 3.36B | 3.66B | 3.40B | 2.56B |
| Net Income | 1.45B | 1.68B | 1.47B | 1.70B | 1.48B | 1.14B |
Balance Sheet | ||||||
| Total Assets | 53.18B | 54.95B | 53.24B | 54.08B | 50.76B | 49.38B |
| Cash, Cash Equivalents and Short-Term Investments | 14.15B | 13.50B | 14.18B | 11.20B | 12.12B | 12.34B |
| Total Debt | 1.09B | 1.50B | 1.08B | 1.19B | 926.00M | 691.00M |
| Total Liabilities | 15.92B | 14.36B | 15.72B | 16.91B | 16.50B | 16.12B |
| Stockholders Equity | 36.65B | 39.91B | 36.60B | 36.33B | 33.52B | 32.60B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 247.00M | 3.64B | 24.00M | 891.00M | 1.30B |
| Operating Cash Flow | 0.00 | 1.35B | 4.43B | 795.00M | 1.78B | 2.06B |
| Investing Cash Flow | 0.00 | -822.00M | -381.00M | -817.00M | -908.00M | -753.00M |
| Financing Cash Flow | 0.00 | -1.25B | -1.15B | -978.00M | -1.19B | -631.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥16.79B | 7.85 | ― | 2.81% | 0.33% | -1.09% | |
74 Outperform | ¥90.04B | 3.56 | ― | 4.28% | 23.37% | 166.37% | |
70 Outperform | ¥124.68B | -37.35 | ― | 2.17% | -5.97% | -55.87% | |
70 Outperform | ¥18.98B | 10.36 | ― | 3.09% | 1.55% | 15.00% | |
70 Outperform | ¥121.53B | 9.45 | ― | 1.92% | 13.77% | 39.53% | |
68 Neutral | ¥66.31B | 10.12 | ― | 3.27% | 5.30% | 15.22% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |